Indications

• It is indicated for the treatment of acute uncomplicated Plasmodium falciparum malaria in adult, children and infants of 5kg and above
  

Key Benefits

• The antimalarial activity of the combination of lumefantrine and artemether in Riamet is greater than that of either substance alone
  
  
• Both artemether and lumefantrine have a secondary action involving inhibition of nucleic acid- and protein synthesis within the malarial parasite.